557 related articles for article (PubMed ID: 30058046)
1. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
Walsh PR; Johnson S
Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
[TBL] [Abstract][Full Text] [Related]
2. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
Monet-Didailler C; Chevallier A; Godron-Dubrasquet A; Allard L; Delmas Y; Contin-Bordes C; Brissaud O; Llanas B; Harambat J
Nephrol Dial Transplant; 2020 Dec; 35(12):2147-2153. PubMed ID: 31411695
[TBL] [Abstract][Full Text] [Related]
3. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.
Westra D; Wetzels JF; Volokhina EB; van den Heuvel LP; van de Kar NC
Neth J Med; 2012 Apr; 70(3):121-9. PubMed ID: 22516576
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
[TBL] [Abstract][Full Text] [Related]
5. Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
Percheron L; Gramada R; Tellier S; Salomon R; Harambat J; Llanas B; Fila M; Allain-Launay E; Lapeyraque AL; Leroy V; Adra AL; Bérard E; Bourdat-Michel G; Chehade H; Eckart P; Merieau E; Piètrement C; Sellier-Leclerc AL; Frémeaux-Bacchi V; Dimeglio C; Garnier A
Pediatr Nephrol; 2018 Aug; 33(8):1385-1394. PubMed ID: 29572749
[TBL] [Abstract][Full Text] [Related]
6. Treatment and management of children with haemolytic uraemic syndrome.
Walsh PR; Johnson S
Arch Dis Child; 2018 Mar; 103(3):285-291. PubMed ID: 28899876
[TBL] [Abstract][Full Text] [Related]
7. Renal and neurological involvement in typical Shiga toxin-associated HUS.
Trachtman H; Austin C; Lewinski M; Stahl RA
Nat Rev Nephrol; 2012 Nov; 8(11):658-69. PubMed ID: 22986362
[TBL] [Abstract][Full Text] [Related]
8. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
Mahat U; Matar RB; Rotz SJ
Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
11. Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.
Delmas Y; Vendrely B; Clouzeau B; Bachir H; Bui HN; Lacraz A; Hélou S; Bordes C; Reffet A; Llanas B; Skopinski S; Rolland P; Gruson D; Combe C
Nephrol Dial Transplant; 2014 Mar; 29(3):565-72. PubMed ID: 24293658
[TBL] [Abstract][Full Text] [Related]
12. A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement.
Giordano P; Netti GS; Santangelo L; Castellano G; Carbone V; Torres DD; Martino M; Sesta M; Di Cuonzo F; Resta MC; Gaeta A; Milella L; Chironna M; Germinario C; Scavia G; Gesualdo L; Giordano M
Pediatr Nephrol; 2019 Mar; 34(3):517-527. PubMed ID: 30362078
[TBL] [Abstract][Full Text] [Related]
13. Shiga toxin associated hemolytic uremic syndrome.
Keir LS
Hematol Oncol Clin North Am; 2015 Jun; 29(3):525-39. PubMed ID: 26043390
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
Kakoullis L; Papachristodoulou E; Chra P; Panos G
J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
[TBL] [Abstract][Full Text] [Related]
15. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM; Brophy PD
Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic uremic syndrome in children.
Talarico V; Aloe M; Monzani A; Miniero R; Bona G
Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and mild chronic kidney disease persist following severe haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli O104:H4 in adults.
Derad I; Obermann B; Katalinic A; Eisemann N; Knobloch JK; Sayk F; Wellhöner P; Lehnert H; Solbach W; Süfke S; Steinhoff J; Nitschke M
Nephrol Dial Transplant; 2016 Jan; 31(1):95-103. PubMed ID: 26180049
[TBL] [Abstract][Full Text] [Related]
18. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
19. Where are we with haemolytic uremic syndrome?
Cavero T; Alonso M
Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
[TBL] [Abstract][Full Text] [Related]
20. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]